COVID Rapid Test Confirms Presence of Antibodies

First U.S. clinical trial confirms Clungene® SARS-CoV-2 Virus IgG/IgM 15-minute rapid test accurately identified antibodies in 100% of COVID-positive patients after 13 days

NEWS PROVIDED BY Proven Pharma Jun 15, 2021, 10:00 ET 

A U.S. clinical trial of a COVID-19 rapid test approved by an institutional review board found they are an effective tool for detecting the presence of antibodies in people who have contracted the virus. The trial was conducted by Sharp Healthcare in San Diego, California, and included patients at both in- and out-patient facilities. The trial was carried out before vaccines were widely available. The peer-reviewed original research results were published in the LymphoSign Journal** Read more


New York Blood Center Research

About New York Blood Center: Founded in 1964, New York Blood Center (NYBC) is a nonprofit organization that is one of the largest independent, community-based blood centers in the world.

New York Blood Center Research Confirms Effectiveness of Rapid Serological Test for COVID-19

Clungene® SARS-CoV-2 IgG/IgM Rapid Serology Test Showed High Degree of Sensitivity and Specificity for Detecting COVID-19 Antibodies

NEWS PROVIDED BY Proven Pharma Aug 26, 2020, 13:07 ET

NEW YORK, Aug. 26, 2020 /PRNewswire/ — The New York Blood Center Lindsley F. Kimball Research Institute announced the results of an independent study that showed the Clungene® SARS-CoV-2 Virus (COVID-19) IgG/IgM Rapid Test Cassette possesses a high degree of sensitivity and specificity for detecting COVID-specific antibodies. Read More


Study Further Confirms Relevance of Rapid Serological Tests for COVID-19

Rapid Antibody Tests Are Useful Tools To Determine Past Infections

NEWS PROVIDED BY Proven Pharma  Aug 17, 2020, 10:07 ET

PLYMOUTH MEETING, Pa.Aug. 17, 2020 /PRNewswire/ — An observational study released today revealed 100 percent agreement between a rapid antibody test administered by trained health professionals and the PCR tests widely used to determine COVID-19 infections. Read More


Proven Pharma Named Exclusive Distributor of the Clungene® SARS-CoV-2 IgG/IgM Rapid Serology Test

NEWS PROVIDED BY Proven Pharma  Jul 07, 2020, 10:07 ET

PLYMOUTH MEETING, Pa., July 7, 2020 /PRNewswire/ — Proven Pharmaceuticals, LLC, a service provider to the healthcare and life-science industries, announced today that it is the exclusive authorized U.S. distributor of the Clungene® SARS-CoV-2 Virus (COVID-19) IgG/IgM Rapid Test Cassette. Read More